Synthesis and Characterization of Nano-Sized 4-Aminosalicylic Acid-Sulfamethazine Cocrystals

Drug-drug cocrystals are formulated to produce combined medication, not just to modulate active pharmaceutical ingredient (API) properties. Nano-crystals adjust the pharmacokinetic properties and enhance the dissolution of APIs. Nano-cocrystals seem to enhance API properties by combining the benefit...

Full description

Saved in:
Bibliographic Details
Main Authors: Ala' Salem (Author), Anna Takácsi-Nagy (Author), Sándor Nagy (Author), Alexandra Hagymási (Author), Fruzsina Gősi (Author), Barbara Vörös-Horváth (Author), Tomislav Balić (Author), Szilárd Pál (Author), Aleksandar Széchenyi (Author)
Format: Book
Published: MDPI AG, 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9a6a12700e9346a8a98e7fbd935a7150
042 |a dc 
100 1 0 |a Ala' Salem  |e author 
700 1 0 |a Anna Takácsi-Nagy  |e author 
700 1 0 |a Sándor Nagy  |e author 
700 1 0 |a Alexandra Hagymási  |e author 
700 1 0 |a Fruzsina Gősi  |e author 
700 1 0 |a Barbara Vörös-Horváth  |e author 
700 1 0 |a Tomislav Balić  |e author 
700 1 0 |a Szilárd Pál  |e author 
700 1 0 |a Aleksandar Széchenyi  |e author 
245 0 0 |a Synthesis and Characterization of Nano-Sized 4-Aminosalicylic Acid-Sulfamethazine Cocrystals 
260 |b MDPI AG,   |c 2021-02-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics13020277 
500 |a 1999-4923 
520 |a Drug-drug cocrystals are formulated to produce combined medication, not just to modulate active pharmaceutical ingredient (API) properties. Nano-crystals adjust the pharmacokinetic properties and enhance the dissolution of APIs. Nano-cocrystals seem to enhance API properties by combining the benefits of both technologies. Despite the promising opportunities of nano-sized cocrystals, the research at the interface of nano-technology and cocrystals has, however, been described to be in its infancy. In this study, high-pressure homogenization (HPH) and high-power ultrasound were used to prepare nano-sized cocrystals of 4-aminosalysilic acid and sulfamethazine in order to establish differences between the two methods in terms of cocrystal size, morphology, polymorphic form, and dissolution rate enhancement. It was found that both methods resulted in the formation of form I cocrystals with a high degree of crystallinity. HPH yielded nano-sized cocrystals, while those prepared by high-power ultrasound were in the micro-size range. Furthermore, HPH produced smaller-size cocrystals with a narrow size distribution when a higher pressure was used. Cocrystals appeared to be needle-like when prepared by HPH compared to those prepared by high-power ultrasound, which had a different morphology. The highest dissolution enhancement was observed in cocrystals prepared by HPH; however, both micro- and nano-sized cocrystals enhanced the dissolution of sulfamethazine. 
546 |a EN 
690 |a nano-drugs 
690 |a 4-aminosalicylic acid 
690 |a sulfamethazine 
690 |a cocrystals 
690 |a high-pressure homogenization 
690 |a high-power ultrasound 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 13, Iss 2, p 277 (2021) 
787 0 |n https://www.mdpi.com/1999-4923/13/2/277 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/9a6a12700e9346a8a98e7fbd935a7150  |z Connect to this object online.